Effectiveness of Extracorporeal Shockwave Therapy in the Treatment of Chronic Insertional Achilles Tendinopathy.

Este estudio ha sido identificado como potencialmente de alto impacto. La métrica de alto impacto de OE, basada en la inteligencia artificial, estima la influencia que puede tener un artículo integrando señales procedentes tanto de la revista en la que se publica como del contenido científico del propio artículo. Desarrollado mediante el procesamiento del lenguaje natural más avanzado, el modelo de Alto Impacto de OE predice con mayor precisión el futuro rendimiento de las citas de un estudio que el factor de impacto de la revista por sí solo. Esto permite reconocer antes las investigaciones clínicamente significativas y ayuda a los lectores a centrarse en los artículos con más probabilidades de configurar la práctica futura.

Resumen del estudio

Thirty-one patients with chronic insertional Achilles tendinopathy were randomized to receive low-energy extracorporeal shockwave therapy (ESWT) (n=16) or sham therapy (n=15). The primary outcome of interest was pain on a Visual Analogue Scale (VAS). The secondary outcome of interest was the VAS foot and ankle (VAS-FA) total score and pain, function and other complaints sub-scores. Additionally, the incidence of complications and rescue analgesic use. All outcomes were measured at 2, 3, 4, 6, 12, and 24 weeks post-treatment. The results revealed that VAS pain was statistically significantly improved from baseline at 4 to 12 weeks in the EWST group, and at 12 and 24-weeks in the Sham group (p<0.05 for all). Furthermore, VAS-FA pain sub-scores in the sham group were statistically significantly improved from baseline at both 12 and 24 weeks (p<0.05 for both). However, all other outcomes did not improve from baseline in either the EWST or control groups. Across all timepoints, no statistically significant difference was observed between the EWST and sham groups for all outcomes (p>0.05 for all).